
New treatment options offer hopes of better clinical outcomes for patients suffering from Parkinson disease and its debilitating daily symptoms.

New treatment options offer hopes of better clinical outcomes for patients suffering from Parkinson disease and its debilitating daily symptoms.

Migraines are a common condition, affecting about 38 million people in the United States and about 10% of people worldwide.

Options include Adakveo, Endari (L-glutamine oral powder), hydroxyurea (Droxia, Hydrea, Siklos), Oxbryta (voxelotor), as well as OTC medications, such as aspirin and ibuprofen.

The 2 most common, recommended, and simplified treatments for HCV are glecaprevir/pibrentasvir (Mavyret) and sofosbuvir/velpatasvir (Epclusa).

COVID-19 has spread to 180 countries and territories and includes and caused more than 44,000 so far, but this is not the first time a pandemic has occurred.

Health care providers often encounter patients with high blood pressure, especially systolic, who come and go without proper treatment and eventually end up in the hospital with a heart attack, kidney failure, or a stroke.